87 related articles for article (PubMed ID: 19880538)
21. The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts.
Okada H; Kurita T; Mochizuki T; Morita K; Sato S
Resuscitation; 2007 Sep; 74(3):538-45. PubMed ID: 17391832
[TBL] [Abstract][Full Text] [Related]
22. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
23. Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity.
Deschamps AM; Yarbrough WM; Squires CE; Allen RA; McClister DM; Dowdy KB; McLean JE; Mingoia JT; Sample JA; Mukherjee R; Spinale FG
Circulation; 2005 Mar; 111(9):1166-74. PubMed ID: 15723986
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation status of matrix metalloproteinase 2 in myocardial ischaemia-reperfusion injury.
Sariahmetoglu M; Skrzypiec-Spring M; Youssef N; Jacob-Ferreira AL; Sawicka J; Holmes C; Sawicki G; Schulz R
Heart; 2012 Apr; 98(8):656-62. PubMed ID: 22397940
[TBL] [Abstract][Full Text] [Related]
25. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
[TBL] [Abstract][Full Text] [Related]
26. Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm.
Galagudza M; Kurapeev D; Minasian S; Valen G; Vaage J
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1006-10. PubMed ID: 15145002
[TBL] [Abstract][Full Text] [Related]
27. [Effects of insulin on cardiac function and coronary circulation in acute myocardial ischemia and reperfusion experiment with dogs].
Ma H; Huo JH; Zhang HX; Bian JF; Wang YM; Xiong LZ; Guo WY; Wang HC; Gao F
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3128-32. PubMed ID: 17313765
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen peroxide causes cardiac dysfunction independent from its effects on matrix metalloproteinase-2 activation.
León H; Bautista-López N; Sawicka J; Schulz R
Can J Physiol Pharmacol; 2007; 85(3-4):341-8. PubMed ID: 17612643
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
30. Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart.
Lalu MM; Pasini E; Schulze CJ; Ferrari-Vivaldi M; Ferrari-Vivaldi G; Bachetti T; Schulz R
Eur Heart J; 2005 Jan; 26(1):27-35. PubMed ID: 15615796
[TBL] [Abstract][Full Text] [Related]
31. Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts.
Sakanashi M; Sakanashi M; Sugahara K; Sakanashi M
Clin Exp Pharmacol Physiol; 2007; 34(1-2):55-60. PubMed ID: 17201736
[TBL] [Abstract][Full Text] [Related]
32. Infarct size limitation by adrenomedullin: protein kinase A but not PI3-kinase is linked to mitochondrial KCa channels.
Nishida H; Sato T; Miyazaki M; Nakaya H
Cardiovasc Res; 2008 Jan; 77(2):398-405. PubMed ID: 17706952
[TBL] [Abstract][Full Text] [Related]
33. Pacing-induced dyssynchrony during early reperfusion reduces infarct size.
Vanagt WY; Cornelussen RN; Baynham TC; Van Hunnik A; Poulina QP; Babiker F; Spinelli J; Delhaas T; Prinzen FW
J Am Coll Cardiol; 2007 May; 49(17):1813-9. PubMed ID: 17466233
[TBL] [Abstract][Full Text] [Related]
34. Coronary venous drug infusion in the ischaemic-reperfused isolated rat heart.
Uriuda Y; Wang QD; Li XS; Sjoquist PO; Nordlander R; Ryden L
Cardiovasc Res; 1996 Jan; 31(1):82-92. PubMed ID: 8849592
[TBL] [Abstract][Full Text] [Related]
35. [Precondition with doxycycline administration abates ischemia/reperfusion injury and reduces the expression of matrix metalloproteinase-1/9 in myocardium in rat in vivo].
Wu LM; Fan L; Chen LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):679-82. PubMed ID: 17996137
[TBL] [Abstract][Full Text] [Related]
36. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
37. Myocardial release of nitric oxide during ischaemia and reperfusion: effects of L-arginine and hypercholesterolaemia.
Prasan AM; McCarron HC; Zhang Y; Jeremy RW
Heart Lung Circ; 2007 Aug; 16(4):274-81. PubMed ID: 17420156
[TBL] [Abstract][Full Text] [Related]
38. Delayed cardioprotective effects of WY-14643 are associated with inhibition of MMP-2 and modulation of Bcl-2 family proteins through PPAR-α activation in rat hearts subjected to global ischaemia-reperfusion.
Barlaka E; Ledvényiová V; Galatou E; Ferko M; Čarnická S; Ravingerová T; Lazou A
Can J Physiol Pharmacol; 2013 Aug; 91(8):608-16. PubMed ID: 23889688
[TBL] [Abstract][Full Text] [Related]
39. Rapid ventricular pacing-induced postconditioning attenuates reperfusion injury: effects on peroxynitrite, RISK and SAFE pathways.
Pipicz M; Varga ZV; Kupai K; Gáspár R; Kocsis GF; Csonka C; Csont T
Br J Pharmacol; 2015 Jul; 172(14):3472-83. PubMed ID: 25827015
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart.
Cheung PY; Sawicki G; Wozniak M; Wang W; Radomski MW; Schulz R
Circulation; 2000 Apr; 101(15):1833-9. PubMed ID: 10769285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
